Chongqing Genrix Biopharma: Flat 24‑Hour Performance, 10% Down MTD – A Strategic Entry Point in Chinese Biopharma
Chongqing Genrix Biopharma stocks flat at 24.11 CNY, trading near its 200‑day SMA amid a 10% month‑end decline. A potential rebound awaits if R&D milestones trigger, offering a balanced entry into China’s biopharma sector.
2 minutes to read